The company was actively trying to partner up or sell its medical tech back in early 2020. They were also trying to RM an operating entity into the shell. Hopefully the recent spikes in the stock mean that management is still trying to salvage this thing. I have been buying at .01 and below, as a lottery ticket.
Market Data 
Markets 
AI
